Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178492 | SCV000230581 | benign | not specified | 2015-03-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178492 | SCV000513072 | benign | not specified | 2016-11-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000541798 | SCV000651152 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000178492 | SCV001475849 | benign | not specified | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002292480 | SCV002586199 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | FLNC: BS1 |
Ambry Genetics | RCV002362917 | SCV002663083 | likely benign | Cardiovascular phenotype | 2018-12-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000178492 | SCV004029321 | likely benign | not specified | 2023-07-29 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486734 | SCV004240674 | benign | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003907618 | SCV004720525 | likely benign | FLNC-related disorder | 2019-06-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |